Literature DB >> 23022630

Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme-linked immunosorbent assay (ELISA) using ammonium thiocyanate.

G Almanzar1, B Ottensmeier, J Liese, M Prelog.   

Abstract

Antibody avidity, defined as the strength of binding between antibody and antigen, represents a functional measure of affinity maturation of antibodies. Determination of the antibody avidity is usually performed separating high and low avidity antibodies by dissociating agents, but measurement of the antibody avidity in humans is rather complicated, due to the heterogeneity of the antibodies produced in response to complex antigens, e.g. after vaccinations. The purpose of the present study was to evaluate the experimental determinants of the assessment of avidities of IgG antibodies directed against pertussis toxin (IgG-anti-PT) and filamentous hemagglutinin (IgG-anti-FHA) produced after pertussis vaccination using an adapted ELISA and ammonium thiocyanate (NH(4)SCN) as dissociating agent. Our experiments revealed that the results of avidity testing depend very much on experimental conditions and may over- or underestimate the relative avidity of IgG-anti-PT and IgG-anti-FHA antibodies. Whereas in our findings avidity seems to be independent from the initial antibody concentration in a wide range of measures, RAI depends on NH(4)SCN concentration, time of incubation and temperature of the reaction. The presented method allows an accurate measurement of the IgG antibody avidity against both Bordetella pertussis antigens PT and FHA, using NH(4)SCN as chaotropic agent in concentrations lower than 3.0M for 20 min time of incubation at 37 °C. Different experimental conditions in testing pertussis-specific IgG antibody avidity should be considered in interpretation and comparability of data of different studies.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23022630     DOI: 10.1016/j.jim.2012.09.008

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  16 in total

1.  One size fits all? Antibody avidity measurement against multiple antigens in maternal vaccination studies.

Authors:  Thomas Rice; Beate Kampmann; Beth Holder
Journal:  Virulence       Date:  2017-04-25       Impact factor: 5.882

2.  Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.

Authors:  Raïssa Nadège Caboré; Kirsten Maertens; Alexandre Dobly; Elke Leuridan; Pierre Van Damme; Kris Huygen
Journal:  Virulence       Date:  2017-02-22       Impact factor: 5.882

3.  Mapping Protective Regions on a Three-Dimensional Model of the Moraxella catarrhalis Vaccine Antigen Oligopeptide Permease A.

Authors:  Antonia C Perez; Antoinette Johnson; Ziqiang Chen; Gregory E Wilding; Michael G Malkowski; Timothy F Murphy
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

4.  Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen.

Authors:  Heather E Lynch; Shelley M Stewart; Thomas B Kepler; Gregory D Sempowski; S Munir Alam
Journal:  J Immunol Methods       Date:  2013-12-04       Impact factor: 2.303

5.  Comparison of different enzyme-linked immunosorbent assay methods for avidity determination of antiphospholipid antibodies.

Authors:  Lenka Fialová; Milada Petráčková; Oliver Kuchař
Journal:  J Clin Lab Anal       Date:  2017-01-26       Impact factor: 2.352

6.  Serum autoantibodies directed against transglutaminase-2 have a low avidity compared with alloantibodies against gliadin in coeliac disease.

Authors:  K A Gelderman; A C A D Drop; L A Trouw; H J Bontkes; G Bouma; I M W van Hoogstraten; B M E von Blomberg
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

7.  Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo.

Authors:  Anne-Laure Flamar; Vanessa Contreras; Sandra Zurawski; Monica Montes; Nathatlie Dereuddre-Bosquet; Frédéric Martinon; Jacques Banchereau; Roger Le Grand; Gerard Zurawski; Yves Levy
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

8.  Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.

Authors:  Ally Olotu; Frederic Clement; Erik Jongert; Johan Vekemans; Patricia Njuguna; Francis M Ndungu; Kevin Marsh; Geert Leroux-Roels; Philip Bejon
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

9.  A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses.

Authors:  Takumi Moriuchi; Nao Otsuka; Yukihiro Hiramatsu; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

10.  Assessment of antibody level and avidity against Bordetella pertussis in a cohort of Egyptian individuals aged 1-18 years.

Authors:  Nihal M Ibrahim; Ebtsam M El-Kady; Somiaa A Eissa; Ahmed F Wahby
Journal:  J Adv Res       Date:  2015-03-21       Impact factor: 10.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.